IR English
- News Release
- Monthly Business News Flash
- Summary of Financial Results
- Sugi Holdings Report
- Corporate Governance Basic Policy
- Contacts
News Release
-
2021.07.16
IR情報
Business Alliance between Sugi Pharmacy Co., Ltd. and Omicare Joint Stock Company
-
2021.07.15
IR情報
-
2021.04.28
IR情報
-
2021.04.06
IR情報
Consolidated Financial Results for the Fiscal Year Ended February 28, 2021 (JGAAP)
-
2021.01.25
IR情報
Monthly Business News Flash
FY 2/2022
| Mar. | Apr. | May. | Jun. | Jul. | Aug. |
|---|---|---|---|---|---|
 |
|
|
|
||
| Sep. | Oct. | Nov. | Dec. | Jan. | feb. |
FY 2/2021
| Mar. | Apr. | May. | Jun. | Jul. | Aug. |
|---|---|---|---|---|---|
|
|
|
|
|
|
| Sep. | Oct. | Nov. | Dec. | Jan. | feb. |
|
|
|
|
|
|
|
FY 2/2020
| Mar. | Apr. | May. | Jun. | Jul. | Aug. |
|---|---|---|---|---|---|
|
|
|
|
|
|
| Sep. | Oct. | Nov. | Dec. | Jan. | feb. |
|
|
|
|
|
|
FY 2/2019
| Mar. | Apr. | May. | Jun. | Jul. | Aug. |
|---|---|---|---|---|---|
|
|
|
|
|
|
| Sep. | Oct. | Nov. | Dec. | Jan. | feb. |
|
|
|
|
|
|
FY 2/2018
| Mar. | Apr. | May. | Jun. | Jul. | Aug. |
|---|---|---|---|---|---|
|
|
|
|
|
|
| Sep. | Oct. | Nov. | Dec. | Jan. | feb. |
|
|
|
|
|
|
Summary of Financial Results
FY 2/2022
| First Quarter Results | Supplemental Material | |
| Data File | |
FY 2/2021
| Fourth Quarter Results | Supplemental Material | |
| Data File | |
|
| Third Quarter Results | Supplemental Material | |
| Data File | |
|
| Second Quarter Results | Supplemental Material | |
| Data File | |
|
| First Quarter Results | Supplemental Material | |
| Data File | |
FY 2/2020
| Fourth Quarter Results | Supplemental Material | |
| Data File | |
|
| Third Quarter Results | Supplemental Material | |
| Data File | |
|
| Second Quarter Results | Supplemental Material | |
| Data File | |
|
| First Quarter Results | Supplemental Material | |
| Data File | |
FY 2/2019
| Fourth Quarter Results | Supplemental Material | |
| Data File | |
|
| Third Quarter Results | Supplemental Material | |
| Data File | |
|
| Second Quarter Results | Supplemental Material | |
| Data File | |
|
| First Quarter Results | Supplemental Material | |
| Data File | |
FY 2/2018
| Fourth Quarter Results | Supplemental Material | |
| Data File | |
|
| Third Quarter Results | Supplemental Material | |
| Data File | |
|
| Second Quarter Results | Supplemental Material | |
| Data File | |
|
| First Quarter Results | Supplemental Material | |
| Data File | |
FY 2/2017
| Fourth Quarter Results | Supplemental Material | |
| Data File | |
|
| Third Quarter Results | Supplemental Material | |
| Data File | |
|
| Second Quarter Results | Supplemental Material | |
| Data File | |
|
| First Quarter Results | Supplemental Material | |
| Data File | |
Sugi Holdings Report
| Sugi Holdings Report 2020 | |
Corporate Governance Basic Policy
| SUGI Pharmacy Group Corporate Governance Basic Policy | |
Contacts
Sugi Holdings can now take telephone inquiries from investors in English.
We are pleased to announce that we now have new investor relations contacts on staff who are able to take telephone inquiries in English. Previously, we had asked investors to use email.
We currently release a monthly business news flash on the 10th of each month and financial statements as well as data files every quarter. We would be pleased to receive any inquiries regarding these materials in English by telephone.
We also recommend that investors use email when they have urgent inquiries because of regional time differences.
Name： Makoto Kasai
(General Manager, IR Department & Business Planning Department)
Telephone ： +81-562-45-2744 (Direct)
E-Mail ： ir-info@drug-sugi.co.jp
Sugi Holdings Co., Ltd.
62-1, Shin'e, Yokone-machi, Obu-shi, Aichi, 474-0011 Japan